An important objective of this project will be isolation and characterization of the growth factor (PGF) produced by plerocercoids of the tapeworm, Spirometra mansonoides. Procedures for initial steps of purification have been established and attempts will be made to sensitize appropriate animals to make specific antibodies directed against PGF. With specific antibodies against PGF, a specific radioimmunoassay will be established. Single step isolation of PGF from crude incubation media should also be possible using affinity chromatography. More efficient methods for collection of PGF are being developed including attempts to maintain plerocercoid cells in prolonged tissue culture. Once PGF is purified in sufficient quantities, the amino acid sequence and the primary structure of the molecule will be determined. A second objective will be to determine the effects of PGF in subhuman primates in short-term as well as extended studies. If PGF stimulates growth in monkeys, it is highly conceivable that it will be active in humans. A third objective will be to determine the effects of PGF on metabolism and how these effects relate to other growth factors, such as growth hormone, somatomedin, and insulin. A fourth objective will be to determine what direct effects PGF has in isolated tissue preparations such as hepatocytes, adipocytes, and skeletal muscle and to compare these effects to those of growth hormone and insulin. The effects of PGF on the immune system will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM017226-11
Application #
3151045
Study Section
Endocrinology Study Section (END)
Project Start
1977-01-01
Project End
1986-07-31
Budget Start
1985-02-01
Budget End
1986-07-31
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Phares, K; Kubik, J (1996) The growth factor from plerocercoids of Spirometra mansonoides is both a growth hormone agonist and a cysteine proteinase. J Parasitol 82:210-5
Salem, M A; Phares, C K (1989) The growth factor from plerocercoid larvae of the tapeworm, Spirometra mansonoides, stimulates growth but is not diabetogenic. Proc Soc Exp Biol Med 191:187-92
Phares, C K (1988) Use of receptor affinity chromatography in purification of the growth hormone-like factor produced by plerocercoids of the tapeworm Spirometra mansonoides. J Recept Res 8:645-65
Phares, C K; Watts, D J (1988) The growth hormone-like factor produced by the tapeworm Spirometra mansonoides specifically binds receptors on cultured human lymphocytes. J Parasitol 74:896-8
Salem, M A; Phares, C K (1987) Insulin-like effects in the rat of the purified growth factor from Spirometra mansonoides plerocercoids. Proc Soc Exp Biol Med 185:31-8
Phares, C K; Booth, B J (1987) Antihuman growth hormone (GH) antibodies cross-react with the GH-like factor from plerocercoids of the tapeworm Spirometra mansonoides. Endocrinology 121:1839-44
Phares, C K; Booth, B J (1986) Suppression of receptors for prolactin and estrogen in rat liver due to treatment with the growth hormone analogue produced by the tapeworm Spirometra mansonoides. J Recept Res 6:425-46
Salem, M A; Phares, C K (1986) Some biochemical effects of the growth hormone analogue produced by plerocercoids of the tapeworm Spirometra mansonoides on carbohydrate metabolism of adipose tissue from normal, diabetic, and hypophysectomized rats. J Parasitol 72:498-506